Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) was upgraded by equities researchers at StockNews.com to a “sell” rating in a research report issued on Saturday.
Aptevo Therapeutics Stock Performance
Shares of APVO opened at $2.41 on Friday. Aptevo Therapeutics has a twelve month low of $2.35 and a twelve month high of $207.33. The firm’s fifty day simple moving average is $3.85 and its 200-day simple moving average is $174.10.
Aptevo Therapeutics Company Profile
Read More
- Five stocks we like better than Aptevo Therapeutics
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- What Are Trending Stocks? Trending Stocks Explained
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Aptevo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptevo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.